Q2 2025 Telus Corp Earnings Call Transcript
Key Points
- TELUS Corp (TU) achieved industry-leading customer growth with total mobile and fixed customer additions of 198,000 in Q2 2025.
- The company reported strong financial performance with TTech EBITDA growth, including TELUS Health, of 4%.
- TELUS Health demonstrated robust growth with operating revenue and adjusted EBITDA increasing by 16% and 29%, respectively.
- The strategic expansion of TELUS PureFibre connectivity in Ontario and Quebec is supported by a $2 billion investment, enhancing national scale and product innovation.
- TELUS Corp's commitment to infrastructure investments aligns with federal goals, promoting private investment and innovation in Canada.
- Mobile network revenue declined slightly due to lower mobile phone ARPU, reflecting competitive pressures and reduced overage and roaming revenues.
- The company recorded a non-cash impairment adjustment to goodwill, impacting net income and resulting in a basic EPS of zero.
- TELUS Corp experienced an uptick in churn, attributed to affordability constraints and competitive intensity in the consumer market.
- The company faces ongoing challenges in maintaining ARPU levels amidst competitive pricing pressures in the wireless market.
- TELUS Corp's leverage ratio remains relatively high at 3.7 times, with a target to reduce it to 3 times by 2027.
Good day, everyone. Welcome to the TELUS 2025 Q2 earnings conference call. I would like to introduce your speaker, Mr. Robert Mitchell. Please go ahead.
Hello, everyone. Thank you for joining us today. Our second quarter 2025 results, news release, MD&A, financial statements, and detailed supplemental investor information were posted to our website earlier this morning. On our call today, we will begin with remarks by Darren and Doug. For the Q&A portion, we will be joined by Zainul, Navin, and Tobias.
Briefly, prepared remarks, slides and answers to questions contain forward-looking statements. Actual results could vary from these statements. The assumptions on which they are based and the material risks that could cause them to differ are outlined in our public filings with the securities commissions in Canada and the US, including our second quarter 2025 and our annual 2024 MD&A. And with that, over to you, Darren.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
